[1]王 芊,林玥宏,蔡 虹.肥胖型非酒精性脂肪性肝病的中医药研究现状[J].医学信息,2023,36(01):181-184.[doi:10.3969/j.issn.1006-1959.2023.01.040]
　WANG Qian,LIN Yue-hong,CAI Hong.Research Status of Traditional Chinese Medicine on Obese Nonalcoholic Fatty Liver Disease[J].Journal of Medical Information,2023,36(01):181-184.[doi:10.3969/j.issn.1006-1959.2023.01.040]
点击复制

肥胖型非酒精性脂肪性肝病的中医药研究现状()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年01期
页码:
181-184
栏目:
综述
出版日期:
2023-01-01

文章信息/Info

Title:
Research Status of Traditional Chinese Medicine on Obese Nonalcoholic Fatty Liver Disease
文章编号:
1006-1959（2023）01-0181-04
作者:
王 芊; 林玥宏; 蔡 虹
（1.厦门弘爱医院中医科，福建 厦门 361016；2.厦门弘爱医院肝病科，福建 厦门 361016；3.北京中医药大学第八临床医学院/厦门市中医院肝一科，福建 厦门 361009）
Author(s):
WANG Qian; LIN Yue-hong; CAI Hong
(1.Department of Traditional Chinese Medicine,Xiamen Humanity Hospital,Xiamen 361016,Fujian,China; 2.Department of Hepatology,Xiamen Humanity Hospital,Xiamen 361016,Fujian,China;3.The First Department of Hepatology,the 8th Clinical Medical College of Beijing University of Chinese Medicine/Xiamen Hospital of TCM, Xiamen 361009,Fujian,China)
关键词:
肥胖; 非酒精性脂肪性肝病; 慢性肝病; 胰岛素抵抗
Keywords:
Obesity; Nonalcoholic fatty liver disease; Chronic liver disease; Insulin resistance
分类号:
R246
DOI:
10.3969/j.issn.1006-1959.2023.01.040
文献标志码:
A
摘要:
非酒精性脂肪性肝病（NAFLD）是一种与肥胖相关的代谢并发症在肝脏的病理表现。随着肥胖和代谢综合征（MetS）的流行，NAFLD已成为我国第一大慢性肝病。为探讨中医药在肥胖型NAFLD治疗中的应用，本文从近年来中医对肥胖型NAFLD的认识、中医治疗肥胖型NAFLD的方法等方面进行综述，以期深化中医药对肥胖型NAFLD的认识及优化该病的临床诊治策略。
Abstract:
Nonalcoholic fatty liver disease (NAFLD) is a pathological manifestation of obesity-related metabolic complications in the liver. With the prevalence of obesity and metabolic syndrome (MetS), NAFLD has become the largest chronic liver disease in China. In order to explore the application of traditional Chinese medicine in the treatment of obese NAFLD, this paper reviews the understanding of obese NAFLD and the methods of treating obese NAFLD in recent years, in order to deepen the understanding of obese NAFLD and optimize the clinical diagnosis and treatment strategies of the disease.

参考文献/References:

[1]中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南( 2018年更新版)[J].临床肝胆病杂志,2018,34(5):947－957．[2]中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.肥胖症基层诊疗指南（2019年）[J].中华全科医师杂志,2020,19(2):95-101.[3]国家卫生健康委.中国居民营养与慢性病状况报告(2020年)[J].营养学报,2020,42(6):521.[4]Zhou F,Zhou J,WangW,et al.Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018：Asystematicreviewand meta-analysis[J].Hepatology,2019,70(4):1119-1113.[5]薛芮,范建高.代谢相关脂肪性肝病新定义的国际专家共识简介[J].临床肝胆病杂志,2020,36(6):1224-1227.[6]Romero-Gómez M,Zelber-Sagi S,Trenell M.Treatment of NAFLD with diet, physical activity and exercise[J].Hepatol,2017,67(4):829-846.[7]曾强,杨月欣,贾伟平,等.超重或肥胖人群体重管理专家共识及团体标准[J].中华健康管理学杂志,2018,12(3):200-207.[8]张声生,李军祥.非酒精性脂肪性肝病中医诊疗专家共识意见(2017)[J].临床肝胆病杂志,2017,33(12):2270-2274．[9]段娜,李志红,黄一茜,等.非酒精性脂肪肝中医证候分布特点及相关因素的临床分析[J].新中医,2012,44(7):43-45.[10]张晨阳,何渝熙,姚政,等.基于真实世界与复杂网络的非酒精性脂肪肝中医证候特点研究[J].时珍国医国药,2019,30(12):3027-3030.[11]赵怡玲,张磊,潘丹青,等.非酒精性脂肪性肝病中医痰湿证与血脂、血尿酸关系的临床研究[J].湖北中医药大学学报,2020,22(4):104-107.[12]郑佳连,卢秉久.非酒精性脂肪肝中医证型及相关因素临床分析[J].辽宁中医药大学学报,2015,17(9):168-170.[13]郑珏.非酒精性脂肪肝辨证分型与体重指数、血脂的关系[J].云南中医学院学报,2012,35(6):28-30.[14]裴旭东,张晓虎,褚桂克,等.消脂祛浊方治疗合并肥胖的痰湿型非酒精性单纯性脂肪肝患者临床效果初步研究[J].实用肝脏病杂志,2021,24(3):355-358.[15]王海燕,吕建林,吕文婷,等.加味逍遥散治疗肥胖型青少年非酒精性脂肪肝的疗效评价[J].中医临床研究,2019,11(27):18-21.[16]董灿.芪珠方治疗肥胖型非酒精性脂肪性肝病的临床及实验研究[D].南京:南京中医药大学,2020.[17]姜昌明,黄晓莺.荷叶参黄汤治疗非酒精性脂肪肝的临床疗效及对肝功能的影响研究[J].四川中医,2021,39(11):124-127.[18]郭海燕,杨皓然,崔桂婷,等.健脾清热化湿法治疗非酒精性脂肪性肝病患者的临床观察[J].世界中西医结合杂志,2021,16(8):1525-1529.[19]巴明玉,娄永强,禄保平.健脾疏肝降脂方对NAFLD肥胖小鼠肝指数、血脂水平及病理组织学的影响[J].中医学报,2020,35(8):1723-1726.[20]杨洪超,徐龙进,孙建光.健脾化浊饮对代谢相关脂肪性肝病大鼠肠肝轴体系影响的研究[J].现代中西医结合杂志,2021,30(24):2623-2630,2696.[21]李艳.黄芪散调控FABP4表达改善肥胖和非酒精性脂肪肝的机制研究[D].广州:广州中医药大学,2017.[22]董嘉琪,陈金鹏,龚苏晓,等.山楂的化学成分、药理作用及质量标志物（Q-Marker）预测[J].中草药,2021,52(9):2801-2818.[23]董玉洁,蒋沅岐,刘毅,等.决明子的化学成分、药理作用及质量标志物预测分析[J].中草药,2021,52(9):2719-2732.[24]高振华,孙伶俐,王豪,等.荷叶化学成分及其药理活性研究[J].广东化工,2020,47(5):100-102.[25]张珊珊.“疏肝降脂”针法对非酒精性脂肪肝伴肥胖（肝郁脾虚型）的临床观察[D].长春:长春中医药大学,2021.[26]王海英,梁翠梅,崔静文,等.针刺通过抑制肝脏氧化应激改善腹型肥胖型非酒精性脂肪肝病大鼠的肝脏脂质代谢[J].针刺研究,2019,44(3):189-194,215.[27]刘洁.电针治疗肥胖合并脂肪肝的临床研究[J].内蒙古中医药,2019,38(10):114-115.[28]董灿,张彩荣,薛博瑜,等．电针结合生活方式控制治疗肥胖型非酒精性脂肪性肝病:随机对照研究[J].中国针灸,2020,40(2):129-134．[29]欧增健.穴位埋线结合行为控制对肥胖型非酒精性脂肪性肝病临床疗效观察[D].南京:南京中医药大学,2020.[30]王芹,滕金艳,姚敏,等.穴位埋线治疗痰湿体质单纯性肥胖合并非酒精性脂肪肝的疗效[J].中西医结合肝病杂志,2020,30(5):457-459.[31]罗丽红,赖秀娟,张惠莲.电针与穴位埋线治疗单纯性肥胖合并脂肪肝患者效果对比观察[J].中医临床研究,2020,12(13):30-33. [32]陈志蕊.穴位埋线治疗单纯性肥胖合并脂肪肝的临床研究[D].合肥:安徽中医药大学,2018.[33]周凌云,陈章妹.穴位埋线治疗腹型肥胖合并单纯性脂肪肝的临床疗效观察[J].内蒙古中医药,2017,36(23):161-162.[34]冯舒婷,李嫦,孙风凡,等.拔罐辅助治疗非酒精性脂肪性肝病临床疗效观察[J].上海针灸杂志,2017,36(12):1411-1414．[35]李辉,秦鉴.治疗肥胖及其代谢并发症的新方法-无饥饿禁食疗法[J].中西医结合肝病杂志,2018,28(6):321-324.[36]杨卯勤,薛敬东,李粉萍,等.中医无饥饿禁食疗法对非酒精性脂肪肝患者糖脂代谢和肝脏脂肪沉积的影响[J].中国医药导报,2020,17(4):135-138.

相似文献/References:

[1]向姣姣,李国娟,杨通艳,等.肠道菌群与肥胖发病机制的研究[J].医学信息,2022,35(10):70.[doi:10.3969/j.issn.1006-1959.2022.10.017]
　XIANG Jiao-jiao,LI Guo-juan,YANG Tong-yan,et al.Study on Intestinal Flora and Pathogenesis of Obesity[J].Journal of Medical Information,2022,35(01):70.[doi:10.3969/j.issn.1006-1959.2022.10.017]
[2]冯贺强,张彩红.肠道菌群与非酒精性脂肪肝关系的研究进展[J].医学信息,2018,31(12):47.[doi:10.3969/j.issn.1006-1959.2018.12.015]
　FENG He-qiang,ZHANG Cai-hong.Research Progress on the Relationship between Intestinal Flora and Nonalcoholic Fatty Liver[J].Journal of Medical Information,2018,31(01):47.[doi:10.3969/j.issn.1006-1959.2018.12.015]
[3]刘 静.利拉鲁肽联合基础胰岛素对初诊2型糖尿病合并肥胖患者 血糖控制及体质量指数的影响[J].医学信息,2018,31(13):137.[doi:10.3969/j.issn.1006-1959.2018.13.040]
　LIU Jing.Effect of Liraglutide Combined with Basal Insulin on Blood Glucose Control and Body Mass Index in Newly Diagnosed Type 2 Diabetes Patients with Obesity[J].Journal of Medical Information,2018,31(01):137.[doi:10.3969/j.issn.1006-1959.2018.13.040]
[4]曾利文,陈 静,张 晔,等.多囊卵巢综合征患者的糖代谢特点分析[J].医学信息,2019,32(02):103.[doi:10.3969/j.issn.1006-1959.2019.02.029]
　ZENG Li-wen,CHEN Jing,ZHANG Ye,et al.Analysis of Characteristics of Glucose Metabolism in Patients with Polycystic Ovarian Syndrome[J].Journal of Medical Information,2019,32(01):103.[doi:10.3969/j.issn.1006-1959.2019.02.029]
[5]郑 颖,孙华胜,毛乾国.中医防治非酒精性脂肪性肝病研究进展[J].医学信息,2018,31(15):25.[doi:10.3969/j.issn.1006-1959.2018.15.010]
　ZHENG Ying,SUN Hua-sheng,MAO Qian-guo.Progress in Prevention and Treatment of Nonalcoholic Fatty Liver Disease by TCM[J].Journal of Medical Information,2018,31(01):25.[doi:10.3969/j.issn.1006-1959.2018.15.010]
[6]李珊珊,陈少彬,龚先琼.中药单体治疗非酒精性脂肪性肝病研究进展[J].医学信息,2018,31(21):24.[doi:10.3969/j.issn.1006-1959.2018.21.008]
　LI Shan-shan,CHEN Shao-bin,GONG Xian-qiong.Advances in Research of Traditional Chinese Medicine Monomer in the Treatment of Non-alcoholic Fatty Liver Disease[J].Journal of Medical Information,2018,31(01):24.[doi:10.3969/j.issn.1006-1959.2018.21.008]
[7]褚福行,李珊珊,李思琪,等.慢性牙周炎伴肥胖患者血清中IL-6、IL-18表达水平的研究[J].医学信息,2019,32(01):92.[doi:10.3969/j.issn.1006-1959.2019.01.028]
　CHU Fu-xing,LI Shan-shan,LI Si-qi,et al.Study on the Expression Levels of IL-6 and IL-18 in Serum of Patients with Chronic Periodontitis and Obesity[J].Journal of Medical Information,2019,32(01):92.[doi:10.3969/j.issn.1006-1959.2019.01.028]
[8]黄玲玉,孙 东,蒋本君,等.天津市某区域体检人群非酒精性脂肪肝调查分析[J].医学信息,2019,32(04):99.[doi:10.3969/j.issn.1006-1959.2019.04.032]
　HUANG Ling-yu,SUN Dong,JIANG Ben-jun,et al.Investigation and Analysis of Non-alcoholic Fatty Liver Disease in Medical Examination Population in A Certain Area of Tianjin[J].Journal of Medical Information,2019,32(01):99.[doi:10.3969/j.issn.1006-1959.2019.04.032]
[9]左俊芳,刘沙沙,崔洪艳.妊娠期糖尿病高危因素及预防措施研究[J].医学信息,2022,35(17):177.[doi:10.3969/j.issn.1006-1959.2022.17.048]
　ZUO Jun-fang,LIU Sha-sha,CUI Hong-yan.Study on High Risk Factors and Preventive Measures of Gestational Diabetes Mellitus[J].Journal of Medical Information,2022,35(01):177.[doi:10.3969/j.issn.1006-1959.2022.17.048]
[10]程晴晴,李元海,夏晓琼,等.超声联合神经刺激仪臂丛神经干精准阻滞在肥胖患者上肢手术中的应用[J].医学信息,2019,32(19):94.[doi:10.3969/j.issn.1006-1959.2019.19.028]
　CHENG Qing-qing,LI Yuan-hai,XIA Xiao-qiong,et al.Application of Ultrasound Combined with Neurostimulator for Brachial Plexus Nerve Block in Upper Limb Surgery in Obese Patients[J].Journal of Medical Information,2019,32(01):94.[doi:10.3969/j.issn.1006-1959.2019.19.028]
[11]龙 颖,李运泽,汤中敏,等.非酒精性脂肪性肝病与血尿酸水平测定及其临床意义[J].医学信息,2018,31(07):92.[doi:10.3969/j.issn.1006-1959.2018.07.029]
　LONG Ying,LI Yun-ze,TANG Zhong-min,et al.Determination of Serum Uric Acid Level and its Clinical Significance in Non-alcoholic Fatty Liver Disease[J].Journal of Medical Information,2018,31(01):92.[doi:10.3969/j.issn.1006-1959.2018.07.029]
[12]刘 英,崔姗姗,暴素青,等.代谢相关性脂肪性肝病与代谢综合征的研究[J].医学信息,2022,35(01):1.[doi:10.3969/j.issn.1006-1959.2022.01.001]
　LIU Ying,CUI Shan-shan,BAO Su-qing,et al.Study on Metabolic-associated Fatty Liver Disease and Metabolic Syndrome[J].Journal of Medical Information,2022,35(01):1.[doi:10.3969/j.issn.1006-1959.2022.01.001]
[13]崔姗姗,刘 英,江 霞.非酒精性脂肪性肝病与胰岛素抵抗的研究进展[J].医学信息,2022,35(10):66.[doi:10.3969/j.issn.1006-1959.2022.10.016]
　CUI Shan-shan,LIU Ying,JIANG Xia.Research Progress on Non-alcoholic Fatty Liver Disease and Insulin Resistance[J].Journal of Medical Information,2022,35(01):66.[doi:10.3969/j.issn.1006-1959.2022.10.016]

更新日期/Last Update: 1900-01-01